2024 NJMS Convocation Speaker – Dr. Jason Chien

Jason is the Chief Medical Officer at Mozart Therapeutics. As a physician scientist, he brings nearly 30 years of experience from the academic, healthcare, and biopharmaceutical industry. Prior to Mozart, Jason was Vice President of Respiratory Infection R&D Strategy and Infectious Diseases Clinical Translational Sciences at Janssen, Pharmaceutical Companies of Johnson & Johnson, where he oversaw the development of a preclinical and clinical pipeline that introduced innovative platforms and strategic concepts as well as extended traditional infectious diseases approaches. Prior to Janssen, Jason led the clinical development team at Gilead Sciences that advanced early and late phase programs in lung fibrosis, respiratory infections and immunology-driven diseases. His industry career is preceded by a distinguished NIH-funded academic career at the University of Washington and the Fred Hutchison Cancer Research Center. He obtained his undergraduate degree from University of Michigan, his Doctorate of Medicine from Rutgers New Jersey Medical School, and his Masters of Science in Genetic Epidemiology from University of Washington. His post-graduate training includes Internal Medicine Residency and Infectious Diseases Fellowship at Case Western Reserve University, and Pulmonary and Critical Care Medicine Fellowship at the University of Washington. 

https://www.mozart-tx.com/about/#leadership